• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可溶性 RANKL 有助于成年小鼠破骨细胞的形成,但不能导致去卵巢诱导的骨丢失。

Soluble RANKL contributes to osteoclast formation in adult mice but not ovariectomy-induced bone loss.

机构信息

Center for Musculoskeletal Disease Research, University of Arkansas for Medical Sciences, Little Rock, 72205, AR, USA.

Department of Orthopaedic Surgery, University of Arkansas for Medical Sciences, Little Rock, 72205, AR, USA.

出版信息

Nat Commun. 2018 Jul 25;9(1):2909. doi: 10.1038/s41467-018-05244-y.

DOI:10.1038/s41467-018-05244-y
PMID:30046091
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6060116/
Abstract

Receptor activator of NFkB ligand (RANKL) is a TNF-family cytokine required for osteoclast formation, as well as immune cell and mammary gland development. It is produced as a membrane-bound protein that can be shed to form a soluble protein. We created mice harboring a sheddase-resistant form of RANKL, in which soluble RANKL is undetectable in the circulation. Lack of soluble RANKL does not affect bone mass or structure in growing mice but reduces osteoclast number and increases cancellous bone mass in adult mice. Nonetheless, the bone loss caused by estrogen deficiency is unaffected by the lack of soluble RANKL. Lymphocyte number, lymph node development, and mammary gland development are also unaffected by the absence of soluble RANKL. These results demonstrate that the membrane-bound form of RANKL is sufficient for most functions of this protein but that the soluble form does contribute to physiological bone remodeling in adult mice.

摘要

核因子 κB 受体激活物配体(RANKL)是一种 TNF 家族细胞因子,对于破骨细胞的形成以及免疫细胞和乳腺的发育是必需的。它作为一种膜结合蛋白被产生,这种膜结合蛋白可以被脱落形成一种可溶性蛋白。我们构建了一种带有破骨细胞溶解酶抗性形式的 RANKL 的小鼠,其中循环中检测不到可溶性 RANKL。可溶性 RANKL 的缺乏并不影响生长中的小鼠的骨量或结构,但减少了成年小鼠的破骨细胞数量并增加了小梁骨量。尽管如此,雌激素缺乏引起的骨丢失不受可溶性 RANKL 的缺乏影响。淋巴细胞数量、淋巴结发育和乳腺发育也不受可溶性 RANKL 缺乏的影响。这些结果表明,RANKL 的膜结合形式足以发挥该蛋白的大多数功能,但可溶性形式确实有助于成年小鼠的生理性骨重塑。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eac/6060116/c698cb33deb8/41467_2018_5244_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eac/6060116/dd96f1861be9/41467_2018_5244_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eac/6060116/16cb14e70508/41467_2018_5244_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eac/6060116/c698cb33deb8/41467_2018_5244_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eac/6060116/dd96f1861be9/41467_2018_5244_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eac/6060116/16cb14e70508/41467_2018_5244_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eac/6060116/c698cb33deb8/41467_2018_5244_Fig3_HTML.jpg

相似文献

1
Soluble RANKL contributes to osteoclast formation in adult mice but not ovariectomy-induced bone loss.可溶性 RANKL 有助于成年小鼠破骨细胞的形成,但不能导致去卵巢诱导的骨丢失。
Nat Commun. 2018 Jul 25;9(1):2909. doi: 10.1038/s41467-018-05244-y.
2
RANKL (Receptor Activator of NFκB Ligand) Produced by Osteocytes Is Required for the Increase in B Cells and Bone Loss Caused by Estrogen Deficiency in Mice.骨细胞产生的RANKL(核因子κB受体激活剂配体)是小鼠雌激素缺乏引起的B细胞增加和骨质流失所必需的。
J Biol Chem. 2016 Nov 25;291(48):24838-24850. doi: 10.1074/jbc.M116.742452. Epub 2016 Oct 12.
3
Receptor activator of nuclear factor κB ligand (RANKL) protein expression by B lymphocytes contributes to ovariectomy-induced bone loss.B 淋巴细胞核因子 κB 受体激活剂配体 (RANKL) 蛋白的表达促进卵巢切除诱导的骨丢失。
J Biol Chem. 2012 Aug 24;287(35):29851-60. doi: 10.1074/jbc.M112.377945. Epub 2012 Jul 10.
4
Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency.前列腺素E2诱导前B细胞上核因子κB受体激活剂配体/骨保护素配体的表达:对雌激素缺乏时破骨细胞生成加速的影响。
J Bone Miner Res. 2000 Jul;15(7):1321-9. doi: 10.1359/jbmr.2000.15.7.1321.
5
LIGHT/TNFSF14 regulates estrogen deficiency-induced bone loss.LIGHT/TNFSF14 调节雌激素缺乏引起的骨丢失。
J Pathol. 2020 Apr;250(4):440-451. doi: 10.1002/path.5385. Epub 2020 Feb 25.
6
Ablation of p38α MAPK Signaling in Osteoblast Lineage Cells Protects Mice From Bone Loss Induced by Estrogen Deficiency.成骨细胞谱系细胞中p38α丝裂原活化蛋白激酶信号的缺失可保护小鼠免受雌激素缺乏诱导的骨质流失。
Endocrinology. 2015 Dec;156(12):4377-87. doi: 10.1210/en.2015-1669. Epub 2015 Oct 6.
7
Dehydrodiconiferyl Alcohol Inhibits Osteoclast Differentiation and Ovariectomy-Induced Bone Loss through Acting as an Estrogen Receptor Agonist.去氢二松柏醇通过作为雌激素受体激动剂抑制破骨细胞分化和卵巢切除诱导的骨丢失。
J Nat Prod. 2018 Jun 22;81(6):1343-1356. doi: 10.1021/acs.jnatprod.7b00927. Epub 2018 Jun 5.
8
Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.衰老会增加基质/成骨细胞诱导的破骨细胞生成,并改变小鼠体内破骨细胞前体细胞库。
J Bone Miner Res. 2005 Sep;20(9):1659-68. doi: 10.1359/JBMR.050503. Epub 2005 May 2.
9
Melatonin at pharmacologic doses increases bone mass by suppressing resorption through down-regulation of the RANKL-mediated osteoclast formation and activation.药理剂量的褪黑素通过下调RANKL介导的破骨细胞形成和激活来抑制骨吸收,从而增加骨量。
J Bone Miner Res. 2002 Jul;17(7):1219-29. doi: 10.1359/jbmr.2002.17.7.1219.
10
WSS25, a sulfated polysaccharide, inhibits RANKL-induced mouse osteoclast formation by blocking SMAD/ID1 signaling.硫酸化多糖WSS25通过阻断SMAD/ID1信号传导抑制RANKL诱导的小鼠破骨细胞形成。
Acta Pharmacol Sin. 2015 Sep;36(9):1053-64. doi: 10.1038/aps.2015.65. Epub 2015 Aug 24.

引用本文的文献

1
Osteocytes function as biomechanical signaling hubs bridging mechanical stress sensing and systemic adaptation.骨细胞作为生物力学信号枢纽,连接着机械应力感知与全身适应性。
Front Physiol. 2025 Jul 15;16:1629273. doi: 10.3389/fphys.2025.1629273. eCollection 2025.
2
Ugonin P mitigates osteolytic bone metastasis by suppressing MDK via upregulating miR-223-3p expression.乌戈宁P通过上调miR-223-3p的表达抑制MDK,从而减轻溶骨性骨转移。
Int J Biol Sci. 2025 May 31;21(8):3740-3754. doi: 10.7150/ijbs.111356. eCollection 2025.
3
Polymorphisms in rs2069845 are associated with IL-6 and soluble IL-6 receptor levels during total joint replacement.

本文引用的文献

1
Secondary osteons scale allometrically in mammalian humerus and femur.在哺乳动物的肱骨和股骨中,继发性骨单位呈异速生长。
R Soc Open Sci. 2017 Nov 8;4(11):170431. doi: 10.1098/rsos.170431. eCollection 2017 Nov.
2
Circulating RANKL and RANKL/OPG and Breast Cancer Risk by ER and PR Subtype: Results from the EPIC Cohort.循环 RANKL 和 RANKL/OPG 与 ER 和 PR 亚型乳腺癌风险的关系:来自 EPIC 队列的结果。
Cancer Prev Res (Phila). 2017 Sep;10(9):525-534. doi: 10.1158/1940-6207.CAPR-17-0125. Epub 2017 Jul 12.
3
Identification of subepithelial mesenchymal cells that induce IgA and diversify gut microbiota.
rs2069845基因多态性与全关节置换术中白细胞介素-6及可溶性白细胞介素-6受体水平相关。
PLoS One. 2025 May 15;20(5):e0312985. doi: 10.1371/journal.pone.0312985. eCollection 2025.
4
The p53-miR17 family-Rankl axis bridges liver-bone communication.p53- miR17家族-Rankl轴介导肝脏与骨骼之间的交流。
Mol Ther. 2025 Feb 5;33(2):631-648. doi: 10.1016/j.ymthe.2024.12.046. Epub 2024 Dec 31.
5
Chrysoeriol: a natural RANKL inhibitor targeting osteoclastogenesis and ROS regulation for osteoporosis therapy.芹菜素:一种靶向破骨细胞生成和ROS调节的天然RANKL抑制剂,用于骨质疏松症治疗。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan 4. doi: 10.1007/s00210-024-03714-3.
6
Metabolic reprogramming in skeletal cell differentiation.骨骼细胞分化中的代谢重编程。
Bone Res. 2024 Oct 11;12(1):57. doi: 10.1038/s41413-024-00374-0.
7
Vertebral marrow fat fraction is associated with circulating RANKL in postmenopausal females.绝经后女性的椎体骨髓脂肪分数与循环 RANKL 相关。
Front Endocrinol (Lausanne). 2024 Sep 16;15:1442046. doi: 10.3389/fendo.2024.1442046. eCollection 2024.
8
RANK-RANKL-OPG Axis in MASLD: Current Evidence Linking Bone and Liver Diseases and Future Perspectives.RANK-RANKL-OPG 轴在 MASLD 中的作用:骨病与肝病关联的当前证据及未来展望。
Int J Mol Sci. 2024 Aug 24;25(17):9193. doi: 10.3390/ijms25179193.
9
RANKL-mediated osteoclast formation is required for bone loss in a murine model of Staphylococcus aureus osteomyelitis.RANKL 介导体细胞形成对于金黄色葡萄球菌骨髓炎小鼠模型的骨质流失是必需的。
Bone. 2024 Oct;187:117181. doi: 10.1016/j.bone.2024.117181. Epub 2024 Jul 1.
10
Bone Regenerative Effect of Injectable Hypoxia Preconditioned Serum-Fibrin (HPS-F) in an Ex Vivo Bone Defect Model.注射用缺氧预处理血清纤维蛋白(HPS-F)在体外骨缺损模型中的骨再生作用。
Int J Mol Sci. 2024 May 13;25(10):5315. doi: 10.3390/ijms25105315.
鉴定诱导 IgA 产生并使肠道微生物组多样化的黏膜下间质细胞。
Nat Immunol. 2017 Jun;18(6):675-682. doi: 10.1038/ni.3732. Epub 2017 Apr 24.
4
RANKL (Receptor Activator of NFκB Ligand) Produced by Osteocytes Is Required for the Increase in B Cells and Bone Loss Caused by Estrogen Deficiency in Mice.骨细胞产生的RANKL(核因子κB受体激活剂配体)是小鼠雌激素缺乏引起的B细胞增加和骨质流失所必需的。
J Biol Chem. 2016 Nov 25;291(48):24838-24850. doi: 10.1074/jbc.M116.742452. Epub 2016 Oct 12.
5
Comparison of circulating tumour necrosis factor superfamily cytokines in periodontitis patients undergoing supportive therapy: a case-controlled cross-sectional study comparing smokers and non-smokers in health and disease.比较接受支持性治疗的牙周炎患者的循环肿瘤坏死因子超家族细胞因子:一项病例对照横断面研究,比较健康和疾病状态下的吸烟者和非吸烟者。
J Clin Periodontol. 2013 Sep;40(9):875-82. doi: 10.1111/jcpe.12134.
6
The osteocyte: an endocrine cell ... and more.骨细胞:一种内分泌细胞……以及更多功能。
Endocr Rev. 2013 Oct;34(5):658-90. doi: 10.1210/er.2012-1026. Epub 2013 Apr 23.
7
Multiplex genome engineering using CRISPR/Cas systems.利用 CRISPR/Cas 系统进行多重基因组工程。
Science. 2013 Feb 15;339(6121):819-23. doi: 10.1126/science.1231143. Epub 2013 Jan 3.
8
Evidence for osteocyte regulation of bone homeostasis through RANKL expression.骨细胞通过 RANKL 表达对骨稳态的调节作用的证据。
Nat Med. 2011 Sep 11;17(10):1231-4. doi: 10.1038/nm.2452.
9
Matrix-embedded cells control osteoclast formation.基质细胞控制破骨细胞的形成。
Nat Med. 2011 Sep 11;17(10):1235-41. doi: 10.1038/nm.2448.
10
Elevated serum receptor activator of nuclear factor kappa B ligand and osteoprotegerin levels in late-onset male hypogonadism.迟发性男性性腺功能减退患者血清核因子κB受体活化因子配体和骨保护素水平升高。
Clin Invest Med. 2011 Aug 1;34(4):E232. doi: 10.25011/cim.v34i4.15365.